Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 860 participants.

Also called NCT07594314

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 860 participants (planned count) (from the registry)
Sponsor
  • Xiang Luo Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07594314
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07594314. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-21 (actual); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)
Condition
Acute Ischemic Stroke
Condition
Vessel Occlusion
Condition
Endovascular Thrombectomy
Condition
Anterior Circulation Brain Infarction
Condition
Minocycline
Intervention (Drug)
Minocycline hydrochloride capsule
Intervention (Drug)
Placebo capsules of Minocycline hydrochloride capsules
Lead sponsor
Xiang Luo (class: other)

Record details

Record id
cardio:ct-nct07594314
Content hash
227744025c63c347e3e144ff10359461fcbbe9626ff45621d8bfb97f900df888